Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,989 | -3,664 | -1,590 | -13,091 | -11,102 |
| Depreciation Amortization | 64 | 42 | 21 | 75 | 56 |
| Accounts receivable | 11 | 20 | 14 | 23 | 20 |
| Other Working Capital | -4 | 195 | -20 | 241 | 236 |
| Other Operating Activity | 7,373 | -174 | -7 | 7,539 | 7,318 |
| Operating Cash Flow | $-5,545 | $-3,581 | $-1,581 | $-5,212 | $-3,471 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -6 | N/A | -11 | N/A |
| Investing Cash Flow | $-18 | $-6 | $N/A | $-11 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 3,250 | 3,250 |
| Common Stock Issued | 3,940 | 30 | N/A | 11,888 | 11,913 |
| Other Financing Activity | -35 | -1 | 5 | -161 | -106 |
| Financing Cash Flow | $3,905 | $29 | $5 | $14,977 | $15,057 |
| Beginning Cash Position | 9,926 | 9,926 | 9,926 | 172 | 172 |
| End Cash Position | 8,268 | 6,368 | 8,350 | 9,926 | 11,758 |
| Net Cash Flow | $-1,658 | $-3,559 | $-1,576 | $9,754 | $11,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,545 | -3,581 | -1,581 | -5,212 | -3,471 |
| Capital Expenditure | -18 | -6 | N/A | -11 | 0 |
| Free Cash Flow | -5,563 | -3,588 | -1,581 | -5,223 | -3,471 |